{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:44Z","timestamp":1707524864110},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,16]]},"DOI":"10.7759\/cureus.33841","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T21:08:55Z","timestamp":1673903335000},"source":"Crossref","is-referenced-by-count":0,"title":["Morvan\u2019s Syndrome: The Importance of Knowing Different Risk-Associated Phenotypes and Antibodies in Identifying the Correct Underlying Tumor"],"prefix":"10.7759","author":[{"given":"Ana Rita","family":"Ramalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Abreu Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 T","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jo\u00e3o","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e8lita","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus F","year":"2021","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, et al.. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021, 8:10.1212\/NXI.0000000000001014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol RS","year":"2018","unstructured":"Grativvol RS, Cavalcante WC, Castro LH, Nitrini R, Simabukuro MM. Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes. Curr Oncol Rep. 2018, 20:92. 10.1007\/s11912-018-0721-y","journal-title":"Curr Oncol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks SN","year":"2018","unstructured":"Binks SN, Klein CJ, Waters P, Pittock SJ, Irani SR. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry. 2018, 89:526-534. 10.1136\/jnnp-2017-315720","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6815","article-title":"Imaging review of paraneoplastic neurologic syndromes","volume":"41","author":"Madhavan AA","year":"2020","unstructured":"Madhavan AA, Carr CM, Morris PP, et al.. Imaging review of paraneoplastic neurologic syndromes. AJNR Am J Neuroradiol. 2020, 41:2176-2187. 10.3174\/ajnr.A6815","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer MJ","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J, et al.. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011, 18:19-e3. 10.1111\/j.1468-1331.2010.03220.x","journal-title":"Eur J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132542-morvans-syndrome-the-importance-of-knowing-different-risk-associated-phenotypes-and-antibodies-in-identifying-the-correct-underlying-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:34Z","timestamp":1707508114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132542-morvans-syndrome-the-importance-of-knowing-different-risk-associated-phenotypes-and-antibodies-in-identifying-the-correct-underlying-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.33841","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,16]]}}}